Information de reference pour ce titreAccession Number: | 00005176-200201000-00004.
|
Author: | Kaul, Ajay
|
Title: | |
Source: | Journal of Pediatric Gastroenterology & Nutrition. 34(1):13-15, January 2002.
|
References: | 1. Brown JC, Cook MA, Dryburgh JR. Motilin, a gastric motor activity-stimulating polypeptide: final purification, amino acid composition, and C-terminal residues. Gastroenterology 1972; 62 (3): 401-4.
2. Brown JC, Mutt V, Dryburgh JR. The Further purification of motilin, a gastric motor activity stimulating polypeptide from the mucosa of the small intestine of hogs. Can J Physiol 1971; 49: 399-405.
3. Coulie B, Tack J, Peeters TL, et al. Involvement of two different pathways in the gastrointestinal motor effects of erythromycin in man. Gut 1998; 43: 395-405.
4. Vantrappen GR, Janssens J, Peeters TL, et al. Motilin and the interdigestive migrating motor complex in man. Dig Dis Sci 1979; 24: 97-500.
5. Bormans V, Peeters TL, Janssens J, et al. In man, only activity fronts that originate in the stomach correlate with motilin peaks. Scand J Gastroenterol 1987; 22: 781-4.
6. Parkman HP, Pagano AP, Vozzelli MA, et al. Gastrokinetic effects of erythromycin: myogenic and neurogenic mechanisms of action in rabbit stomach. Am J Physiol Gastrointest Liver Physiol 1995; 269: G418-26.
7. Miller P, Roy A, St-Pierre S, et al. Motilin receptors in the human antrum. Am J Physiol Gastrointest Liver Physiol 2000; 278: G18-23.
8. Assche VG, Depoortere I, Thijs T, et al. Contractile effects and intracellular Ca2+ signaling induced by motilin and erythromycin in the circular smooth muscle of human colon. Neurogastroenterol Motil 2001; 13 (1): 27-35.
9. Miller P, Trudel L, St-Pierre S, et al. Neural and muscular receptors for motilin in the rabbit colon. Peptides 2000; 21 (2): 283-7.
10. Itoh Z, Nakaya M, Suzuki T, et al. Erythromycin mimics exogenous motilin in gastrointestinal contractile activity in the dog: I. Am J Physiol 1984; 247: G688-94.
11. Peeters T, Matthijs G, Depoortere I, et al. Erythromycin is a motilin receptor agonist: I. Am J Physiol 1989; 257: G470-4.
12. Janssens J, Peeters TL, Vantrappen G, et al. Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies. N Engl J Med 1990; 322: 1028-31.
13. Sarna SK, Soergel KH, Koch TR, et al. Gastrointestinal motor effects of erythromycin in humans. Gastroenterology 1991; 101: 1488-96.
14. Tack J, Janssens J, Vantrappen G, et al. Dose-related effect of erythromycin on gastroduodenal motility and plasma motilin levels. Studies in healthy volunteers and in patients with diabetic gastroparesis. Gastroenterology 1992; 103: 72-9.
15. Furness JB, Clark MJ, Wright T, et al. An action of erythromycin in the intestine that is not mediated via motilin receptors. Clin Exp Pharmacol Physiol 1999; 26: 100-4.
16. Bormans V, Peeters TL, Janssens J, et al. In man, only activity fronts that originate in the stomach correlate with motilin peaks. Scand J Gastroenterol 1987; 22 (7): 781-4.
17. Jadcherla SR, Klee G, Berseth CL. Regulation of migrating motor complexes by motilin and pancreatic polypeptide in human infants. Pediatr Res 1997; 42 (3): 365-9.
18. Berseth CL. Gastrointestinal motility in the neonate. Clin Perinatol 1996; 23 (2): 179-90.
19. Tomomasa T, Miyazaki M, Koizumi T, et al. Erythromycin increases gastric antral motility in human premature infants. Biol Neonate 1993; 63: 349-52.
20. Jadcherla SR, Berseth CL. Efficacy of erythromycin on gastroduodenal contractile activity in developing neonates. J Pediatr Gastroenterol Nutr 2002; 34: 16-22.
21. Costalos C, Gounaris A, Varhalama E, et al. Erythromycin as a prokinetic agent in preterm infants. J Pediatr Gastroenterol Nutr 2002; 34: 23-5.
22. Oei J, Lui K. A placebo-controlled trial of low-dose erythromycin to promote feed tolerance in preterm infants. Acta Paediatr 2001; 90: 904-8.
23. Ng PC, So KW, Fung KSC, et al. Randomized controlled study of oral erythromycin for treatment of gastrointestinal dysmotility in preterm infants. Arch Dis Shild Fetal Neonatal Ed 2001; 84: F177-82.
24. Patole SK, Almonte R, Kadalraja R, et al. Can prophylactic oral erythromycin reduce time to full enteral feeds in preterm neonates? Int J Clin Pract 200;54(8):504-8.
25. Van Herwaarden MA, Samsom M, Van Nispen CH, et al. The effect of motilin agonist ABT-229 on gastro-oesophageal reflux, oesophageal motility and lower oesophageal sphincter characteristics in GERD patients. Aliment Pharmacol Ther 2000; 14 (4): 453-62.
26. Talley NJ, Verlinden M, Snape W, et al. Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther 2000; 14 (12): 1653-61.
27. Talley NJ, Verlinden M, Geenen DJ, et al. Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomized, double blind , placebo controlled trial. Gut 2001; 49 (3): 395-401.
28. Peeters TL. GM-611 (Chugai Pharmaceutical). Curr Opin Investig Drugs 2001; 2 (4): 555-7.
|
Language: | English.
|
Document Type: | Editorial.
|
Journal Subset: | Clinical Medicine. Life Sciences.
|
ISSN: | 0277-2116
|
NLM Journal Code: | jl6, 8211545
|
Annotation(s) | |
|
|